This webinar was recorded in March 2018.
- Review the prevalence/economic impact of allergic rhinitis (AR), also known as nasal allergies or hay fever
- Define what is meant by difficult-to-manage Allergic Rhinitis
- Recognize that optimal AR control is currently not being achieved in many patients
- Discuss the impact of difficult-to-manage AR on quality of life and comorbidities
- Discuss the need for shared decision making for immunotherapy options
Dr. Don Buckstein